Results 151 to 160 of about 49,641 (173)

Remdesivir

Reactions Weekly
Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
  +19 more sources

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses [PDF]

Lancet, The, 2022
Background The Solidarity trial among COVID-19 inpatients has previously reported interim mortality analyses for four repurposed antiviral drugs. Lopinavir, hydroxychloroquine, and interferon (IFN)-beta 1a were discontinued for futility but randomisation
Quarraisha Karim, Srinivas Murthy, Pål Aukrust   +2 more
exaly   +9 more sources

Remdesivir for the Treatment of Covid-19 — Preliminary Report [PDF]

New England Journal of Medicine, 2020
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.
Anas Hadeh
exaly   +2 more sources

Remdesivir and COVID-19

Lancet, The, 2020
Jessie K Edwards, Adaora A Adimora, Stephen R Cole   +2 more
exaly   +4 more sources

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

New England Journal of Medicine, 2022
Robert L Gottlieb, Roger Paredes, Pablo Ryan   +2 more
exaly  

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine, 2021
Andre C Kalil, Thomas F Patterson, Aneesh K Mehta   +2 more
exaly